Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Arthritis Rheumatol. 2017 Mar 31;69(5):1045–1053. doi: 10.1002/art.40032

Table 3. Risk factors for serious infections.

Incident rate ratio (IRR) obtained from univariable and multivariable Poisson regression.

Variables Univariable IRR (95%CI) P value Adjusted IRR (95% CI) P value
Age (per 10 yr) 1.49 (1.24 to 1.80) <0.001 1.46 (1.19 to 1.78) <0.001
Male 0.78 (0.46 to 1.32) 0.34 0.83 (.50 to 1.42) 0.51
MPO 1.76 (1.03 to 3.02) 0.04 1.32 (0.73 to 2.37) 0.36
Time from diagnosis to rituximab (per yr) 0.97 (0.92 to 1.03) 0.30 0.97 (0.91 to 1.04) 0.41
Duration of continuos rituximab before remission (per mo) 0.79 (0.53 to 1.17) 0.24 0.99 (0.69 to 1.41) 0.94
PLEX 0.64 (0.29 to 1.41) 0.27 0.42 (0.19 to 0.96) 0.04
IgG < 400 mg/dL 2.40 (1.22 to 4.72) 0.01 2.13 (1.04 to 4.36) 0.04

Abbreviations: CI, confidence interval; Ig, immunoglobulin; mo, month; MPO, myeloperoxidase; PLEX, plasma exchange; yr, year.